Cite Filings / SYRE / 0001193125-24-077783
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
POS AM

Post-effective Amendment for Registration Statement

Spyre Therapeutics, Inc. · Filed 2024-03-27 · Acc 0001193125-24-077783

Documents 1

  • POS AM Post-effective Amendment for Registration Statement , d518298dposam.htm

Around this filing

  • 2025-03-07 POS AM Post-effective Amendment for Registration Statement
  • 2024-04-01 EFFECT Notice of Effectiveness
  • 2024-03-28 CORRESP Correspondence Between Filers and SEC Staff
  • 2024-03-27 POS AM Post-effective Amendment for Registration Statement
  • 2024-03-27 S-1/A Registration Statement
  • 2024-03-26 CORRESP Correspondence Between Filers and SEC Staff
  • 2024-03-14 POS AM Post-effective Amendment for Registration Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d518298dposam.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…